Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 100% | 658.38 | 359 / 359 | 100% | 10.78 | 286 / 286 |
brain | 100% | 962.86 | 2638 / 2642 | 100% | 17.11 | 705 / 705 |
prostate | 100% | 722.36 | 245 / 245 | 100% | 15.70 | 501 / 502 |
esophagus | 100% | 825.26 | 1442 / 1445 | 100% | 10.45 | 183 / 183 |
kidney | 100% | 593.08 | 89 / 89 | 100% | 13.13 | 899 / 901 |
ovary | 100% | 1072.69 | 180 / 180 | 100% | 17.27 | 429 / 430 |
lung | 100% | 847.91 | 577 / 578 | 100% | 13.00 | 1154 / 1155 |
breast | 100% | 902.54 | 459 / 459 | 100% | 13.57 | 1115 / 1118 |
skin | 100% | 816.01 | 1806 / 1809 | 100% | 16.35 | 471 / 472 |
adrenal gland | 100% | 1170.77 | 258 / 258 | 100% | 37.37 | 229 / 230 |
thymus | 100% | 1062.04 | 652 / 653 | 100% | 19.11 | 603 / 605 |
intestine | 100% | 925.92 | 966 / 966 | 99% | 10.35 | 522 / 527 |
uterus | 100% | 1000.84 | 170 / 170 | 99% | 13.48 | 453 / 459 |
bladder | 100% | 883.81 | 21 / 21 | 98% | 12.31 | 496 / 504 |
pancreas | 97% | 383.67 | 319 / 328 | 99% | 12.01 | 176 / 178 |
liver | 100% | 504.54 | 226 / 226 | 95% | 7.65 | 387 / 406 |
adipose | 100% | 922.20 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 21.40 | 29 / 29 |
spleen | 100% | 1265.91 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 912.81 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 540.79 | 799 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 614.02 | 851 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 13.99 | 79 / 80 |
tonsil | 0% | 0 | 0 / 0 | 98% | 11.29 | 44 / 45 |
peripheral blood | 93% | 1073.34 | 863 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0000724 | Biological process | double-strand break repair via homologous recombination |
GO_0031398 | Biological process | positive regulation of protein ubiquitination |
GO_0016925 | Biological process | protein sumoylation |
GO_0072711 | Biological process | cellular response to hydroxyurea |
GO_0006281 | Biological process | DNA repair |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0032204 | Biological process | regulation of telomere maintenance |
GO_0071478 | Biological process | cellular response to radiation |
GO_0034644 | Biological process | cellular response to UV |
GO_0140588 | Biological process | chromatin looping |
GO_0030915 | Cellular component | Smc5-Smc6 complex |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | NSMCE3 |
Protein name | Non-structural maintenance of chromosomes element 3 homolog (Non-SMC element 3 homolog) (Hepatocellular carcinoma-associated protein 4) (MAGE-G1 antigen) (Melanoma-associated antigen G1) (Necdin-like protein 2) |
Synonyms | NDNL2 MAGEG1 HCA4 |
Description | FUNCTION: Component of the SMC5-SMC6 complex, a complex involved in repair of DNA double-strand breaks by homologous recombination . The complex may promote sister chromatid homologous recombination by recruiting the SMC1-SMC3 cohesin complex to double-strand breaks. The complex is required for telomere maintenance via recombination in ALT (alternative lengthening of telomeres) cell lines and mediates sumoylation of shelterin complex (telosome) components which is proposed to lead to shelterin complex disassembly in ALT-associated PML bodies (APBs). In vitro enhances ubiquitin ligase activity of NSMCE1. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex . May be a growth suppressor that facilitates the entry of the cell into cell cycle arrest (By similarity). . |
Accessions | ENST00000332303.6 Q96MG7 ENST00000631973.1 |